Advertisement

Topics

Gene therapy for primary immune deficiencies: a Canadian perspective

19:00 EST 26 Feb 2017 | Allergy Asthma and Clinical Immunology

The use of gene therapy (GT) for the treatment of primary immune deficiencies (PID) including severe combined immune deficiency (SCID) has progressed significantly in the recent years. In particular, long-term...

Original Article: Gene therapy for primary immune deficiencies: a Canadian perspective

NEXT ARTICLE

More From BioPortfolio on "Gene therapy for primary immune deficiencies: a Canadian perspective"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Gene Therapy
Gene therapy is the use of DNA as a pharmaceutical agent to treat disease. It derives its name from the idea that DNA can be used to supplement or alter genes within an individual's cells as a therapy to treat disease. The most common form of gene th...